Cleared Traditional

K021747 - DEGALL LAPAROSCOPIC GALLBLADDER EXTRACTOR

K021747 is an FDA 510(k) clearance for DEGALL LAPAROSCOPIC GALLBLADDER EXTRACTOR, manufactured by Surgicon, Inc.. The device is a Class 2 General & Plastic Surgery device with product code GCI cleared through the Traditional 510(k) pathway after a 79-day FDA review.

K021747 · Surgicon, Inc. · General & Plastic Surgery device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2002
Decision
79d
Days
Class 2
Risk

K021747 is an FDA 510(k) clearance for the DEGALL LAPAROSCOPIC GALLBLADDER EXTRACTOR. Classified as Laryngoscope, Endoscope (product code GCI), Class II - Special Controls.

Submitted by Surgicon, Inc. (Stratford, US). The FDA issued a Cleared decision on August 15, 2002 after a review of 79 days - a notably fast clearance cycle.

This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 876.1500 - the FDA general and plastic surgery device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Surgicon, Inc. devices

FDA 510(k) Submission Details - K021747

510(k) Number K021747 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 28, 2002
Decision Date August 15, 2002
Days to Decision 79 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
36d faster than avg
Panel avg: 115d · This submission: 79d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GCI Device Classification - Class 2, Special Controls

Product Code GCI Laryngoscope, Endoscope
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 876.1500
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General & Plastic Surgery devices follow this clearance model.

Regulatory Peers - GCI Laryngoscope, Endoscope

All 8
Devices cleared under the same product code (GCI) and FDA review panel - the closest regulatory comparables to K021747.
MODIFICATION TO HERMES OPERATING ROOM CONTROL CENTER
K003222 · Computer Motion, Inc. · Nov 2000
AUTO SUTURE DISPOSABLE ENDOSCOPIC SPECIMEN POUCH
K922123 · United States Surgical, A Division of Tyco Healthc · Feb 1993
GLEESON CLOT-BUSTER
K920139 · Conmedcorp · Apr 1992
POOLE TIP SUCTION PROBE
K915762 · O.R. Concepts, Inc. · Mar 1992
SINGLE USE LAPAROSCOPY ELECTROSURGICAL INSTRUMENT
K914120 · Conmedcorp · Oct 1991
ENDOSTAPLE
K911829 · Ethicon, Inc. · Aug 1991